We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
AUM
$321M
AUM Growth
+$11.5M
Cap. Flow
+$16.1M
Cap. Flow %
5.01%
Top 10 Hldgs %
26.2%
Holding
358
New
36
Increased
93
Reduced
39
Closed
39

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$4.11M
2
GLW icon
Corning
GLW
+$4.02M
3
BAX icon
Baxter International
BAX
+$3.78M
4
BSX icon
Boston Scientific
BSX
+$3.65M
5
CSX icon
CSX Corp
CSX
+$3.5M

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Healthcare 13.54%
3 Financials 12.68%
4 Communication Services 10.01%
5 Consumer Staples 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USNA icon
226
Usana Health Sciences
USNA
$421M
$10K ﹤0.01%
109
YUMC icon
227
Yum China
YUMC
$16.4B
$10K ﹤0.01%
164
CCL icon
228
Carnival Corporation Ltd
CCL
$40.5B
$9K ﹤0.01%
350
MFC icon
229
Manulife Financial
MFC
$74.4B
$9K ﹤0.01%
+463
New +$9K
RIG icon
230
Transocean
RIG
$5.78B
$9K ﹤0.01%
2,500
GILD icon
231
Gilead Sciences
GILD
$168B
$8K ﹤0.01%
115
-63,199
-100% -$4.44M
SCHE icon
232
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
$8K ﹤0.01%
+259
New +$8.09K
CTVA icon
233
Corteva
CTVA
$52.2B
$7K ﹤0.01%
166
NOC icon
234
Northrop Grumman
NOC
$78.4B
$7K ﹤0.01%
20
-26
-57% -$9.4K
OTIS icon
235
Otis Worldwide
OTIS
$28B
$7K ﹤0.01%
+87
New +$7.65K
RCL icon
236
Royal Caribbean
RCL
$87.1B
$7K ﹤0.01%
75
VOE icon
237
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$7K ﹤0.01%
50
CRM icon
238
Salesforce
CRM
$156B
$6K ﹤0.01%
21
+20
+2,000% +$5.08K
MET icon
239
MetLife
MET
$61.9B
$6K ﹤0.01%
96
SPYM
240
State Street SPDR Portfolio S&P 500 ETF
SPYM
$167B
$6K ﹤0.01%
125
XLC icon
241
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
$6K ﹤0.01%
79
XLY icon
242
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
$6K ﹤0.01%
66
COP icon
243
ConocoPhillips
COP
$144B
$5K ﹤0.01%
73
CTAS icon
244
Cintas
CTAS
$81.5B
$5K ﹤0.01%
48
DOCU
245
DocuSign
DOCU
$11B
$5K ﹤0.01%
+20
New +$5.76K
PFF icon
246
iShares Preferred and Income Securities ETF
PFF
$13.3B
$5K ﹤0.01%
129
-2
-2% -$78
SPGI icon
247
S&P Global
SPGI
$122B
$5K ﹤0.01%
12
XLE icon
248
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
$5K ﹤0.01%
200
+20
+11% +$495
XLP icon
249
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$5K ﹤0.01%
70
XLRE icon
250
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.63B
$5K ﹤0.01%
121
-111
-48% -$5.16K

Similar funds

Providence Capital Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Providence Capital Advisors held 358 positions worth $321M, up 3.7% from $309M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Providence Capital Advisors deployed $16.1M of net new capital in Q3 2021, opening 36 new positions and adding to 93 existing holdings. Its largest new stake was Boston Scientific: 82,600 shares worth $3.58M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $4.44M trimmed.

  • Providence Capital Advisors's largest Q3 2021 buy was Boston Scientific: 82,600 shares worth $3.58M.
  • Providence Capital Advisors added most to Starbucks in Q3 2021, an estimated $4.11M increase.
  • Providence Capital Advisors's biggest Q3 2021 reduction was Gilead Sciences, cutting an estimated $4.44M.
  • Providence Capital Advisors fully exited Johnson Controls International in Q3 2021, selling an estimated $3.69M.
  • Providence Capital Advisors's ten largest holdings make up 26% of its $321M portfolio in Q3 2021.
  • Providence Capital Advisors opened 36 new positions and closed 39 in Q3 2021.
  • Providence Capital Advisors's portfolio value rose 3.7% quarter-over-quarter to $321M.

Based on Providence Capital Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.